American Cannabis Valuation
| AMMJ Stock | USD 0 0.0009 900.00% |
American Cannabis seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of American Cannabis from analyzing the firm fundamentals such as profit margin of (0.23) %, and Return On Equity of -0.93 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that American Cannabis' price fluctuation is out of control at this time. Calculation of the real value of American Cannabis is based on 3 months time horizon. Increasing American Cannabis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
American Cannabis' intrinsic value may or may not be the same as its current market price of 0, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 0.001018 | Hype 9.71E-4 | Naive 0.001216 |
The intrinsic value of American Cannabis' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence American Cannabis' stock price.
Estimating the potential upside or downside of American Cannabis helps investors to forecast how American pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of American Cannabis more accurately as focusing exclusively on American Cannabis' fundamentals will not take into account other important factors: American Cannabis Total Value Analysis
American Cannabis is presently expected to have valuation of 3.49 M with market capitalization of 2.11 M, debt of 806.73 K, and cash on hands of 873.76 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the American Cannabis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.49 M | 2.11 M | 806.73 K | 873.76 K |
American Cannabis Investor Information
About 25.0% of the company shares are held by company insiders. The book value of American Cannabis was presently reported as 0.02. The company recorded a loss per share of 0.02. American Cannabis had not issued any dividends in recent years. The entity had 1:8484 split on the . Based on the key indicators related to American Cannabis' liquidity, profitability, solvency, and operating efficiency, American Cannabis is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.American Cannabis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. American Cannabis has an asset utilization ratio of 57.43 percent. This denotes that the Company is making $0.57 for each dollar of assets. An increasing asset utilization means that American Cannabis is more efficient with each dollar of assets it utilizes for everyday operations.American Cannabis Ownership Allocation
American Cannabis holds a total of 85.73 Million outstanding shares. American Cannabis retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.American Cannabis Profitability Analysis
The company reported the previous year's revenue of 2.43 M. Net Loss for the year was (1.44 M) with profit before overhead, payroll, taxes, and interest of 1.06 M.About American Cannabis Valuation
An absolute valuation paradigm, as applied to American Pink Sheet, attempts to find the value of American Cannabis based on its fundamental and basic technical indicators. By analyzing American Cannabis's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of American Cannabis's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of American Cannabis. We calculate exposure to American Cannabis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of American Cannabis's related companies.American Cannabis Company, Inc., together with its subsidiary, Hollister Blacksmith, Inc., provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. American Cannabis Company, Inc. was founded in 2013 and is headquartered in Denver, Colorado. American Cannabis operates under Consulting Services classification in the United States and is traded on OTC Exchange. It employs 7 people.
8 Steps to conduct American Cannabis' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates American Cannabis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct American Cannabis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain American Cannabis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine American Cannabis' revenue streams: Identify American Cannabis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research American Cannabis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish American Cannabis' growth potential: Evaluate American Cannabis' management, business model, and growth potential.
- Determine American Cannabis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate American Cannabis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
American Cannabis Growth Indicators
Investing in growth stocks can be very risky. If the company such as American Cannabis does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 81.9 M | |
| Retained Earnings | -9.4 M |
Other Information on Investing in American Pink Sheet
American Cannabis financial ratios help investors to determine whether American Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Cannabis security.